We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Compound Targets the Link Between Poor Diet, Inflammation and Alzheimer's Disease

Article   Nov 26, 2019 | by Ruairi J Mackenzie, Science Writer for Technology Networks

 
New Compound Targets the Link Between Poor Diet, Inflammation and Alzheimer's Disease
 
 
 

RELATED ARTICLES

The Neuroscience of Psychedelic Drugs: Ending Psychedelic Myths With Professor David Nutt

Article

Professor David Nutt has never been afraid to stick his head above the parapet on the topic of drugs. His repeated calling-out of the failures of contemporary drug policy has seen him butt heads with academics and politicians alike. In this interview with Professor Nutt, we discuss pot, policy and the potential of psilocybin.

READ MORE

Scientists Left Perplexed at Latest Alzheimer’s Drug Data

Article

In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.

READ MORE

The Neuroscience of Psychedelic Drugs: Octopuses, MDMA and Healing Social Injury

Article

In our latest interview series, we discuss the potential of psychedelics to revolutionize clinical neuroscience with thought leaders in the field. In this first interview of our series exploring the Neuroscience of Psychedelics, we talk to Johns Hopkins Associate Professor Gul Dölen, who has spent years exploring the effects of MDMA on the mammalian (and more recently, cephalopod) brain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE